Inventor · disambiguated record
Dayong Zhai
Also filed as: ZHAI DAYONG
21 granted patents·13 pending applications·90 citations·filing 2007–2025
94Inventor score
Files withTURNING POINT THERAPEUTICS INC26TP THERAPEUTICS INC4BLOSSOMHILL THERAPEUTICS INC1BURNHAM INST1BURNHAM INST MEDICAL RESEARCH1
Top patents by PatentIndex Score
34 records- 0196US10246466B2Diaryl macrocycles as modulators of protein kinasesTP THERAPEUTICS INC·Filed 2017·Granted Apr 2, 2019·18 cites·17 claims
- 0296US9714258B2Diaryl macrocycles as modulators of protein kinasesTP THERAPEUTICS INC·Filed 2015·Granted Jul 25, 2017·25 cites·22 claims
- 0395US11155563B2Macrocyclic compounds and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2021·Granted Oct 26, 2021·3 cites·3 claims
- 0494US10745416B2Macrocyclic compounds for treating diseaseTURNING POINT THERAPEUTICS INC·Filed 2020·Granted Aug 18, 2020·4 cites·29 claims
- 0593US10618912B2Diaryl macrocycles as modulators of protein kinasesTURNING POINT THERAPEUTICS INC·Filed 2018·Granted Apr 14, 2020·5 cites·19 claims
- 0692US11142533B2Macrocycles for use in treating diseaseTURNING POINT THERAPEUTICS INC·Filed 2021·Granted Oct 12, 2021·2 cites·3 claims
- 0792US10689400B2Macrocycle kinase inhibitorsTURNING POINT THERAPEUTICS INC·Filed 2017·Granted Jun 23, 2020·7 cites·19 claims
- 0892US10316044B2Chiral diaryl macrocycles as modulators of protein kinasesTP THERAPEUTICS INC·Filed 2016·Granted Jun 11, 2019·18 cites·22 claims
- 0991US11981684B2Macrocyclic compounds and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2022·Granted May 14, 2024·1 cites·20 claims
- 1091US11286264B2Macrocyclic compounds and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2018·Granted Mar 29, 2022·4 cites·21 claims
- 1185US11452725B2Chiral diaryl macrocycles and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·1 cites·20 claims
- 1284US11634433B2Macrocycles for use in treating diseaseTURNING POINT THERAPEUTICS INC·Filed 2020·Granted Apr 25, 2023·1 cites·17 claims
- 1383US12404281B2Diaryl macrocycles as modulators of protein kinasesTURNING POINT THERAPEUTICS INC·Filed 2023·Granted Sep 2, 2025·0 cites·7 claims
- 1479US12310968B2Chiral diaryl macrocycles and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2022·Granted May 27, 2025·0 cites·27 claims
- 1577US11291667B2Combination therapy involving diaryl macrocyclic compoundsTURNING POINT THERAPEUTICS INC·Filed 2018·Granted Apr 5, 2022·1 cites·15 claims
- 1677US2025375451A1Chiral diaryl macrocycles and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1777US2022112213A1Diaryl macrocycles as modulators of protein kinasesTURNING POINT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1875US2023322806A1Macrocycles for use in treating diseaseTURNING POINT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1972US2022306652A1Macrocyclic compounds for treating diseaseTURNING POINT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2071US11286265B2Macrocyclic compounds for treating diseaseTURNING POINT THERAPEUTICS INC·Filed 2020·Granted Mar 29, 2022·0 cites·15 claims
- 2170US2020216465A1Diaryl macrocycles as modulators of protein kinasesTURNING POINT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2269US2024033266A1Combination therapy involving diaryl macrocyclic compoundsTURNING POINT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2367US2023398119A1Combination therapy involving diaryl macrocyclic compoundsTURNING POINT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2463US11654145B2Combination therapy involving diaryl macrocyclic compoundsTURNING POINT THERAPEUTICS INC·Filed 2020·Granted May 23, 2023·0 cites·30 claims
- 2563US2025074920A1Macrocyclic compounds and use as kinase inhibitorsBLOSSOMHILL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2662US11666574B2Combination therapy involving diaryl macrocyclic compoundsTURNING POINT THERAPEUTICS INC·Filed 2020·Granted Jun 6, 2023·0 cites·17 claims
- 2761USRE50634EDiaryl macrocycles as modulators of protein kinasesTURNING POINT THERAPEUTICS INC·Filed 2015·Granted Oct 14, 2025·0 cites·24 claims
- 2855US2025262216A1Therapeutic uses of macrocyclic compoundsTURNING POINT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2954US11008337B2Chiral diaryl macrocycles as modulators of protein kinasesTURNING POINT THERAPEUTICS INC·Filed 2019·Granted May 18, 2021·0 cites·22 claims
- 3053US2018325901A1Chiral diaryl macrocycles and uses thereofTP THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3151US2009163577A1METHODS AND COMPOSITIONS FOR ANTAGONIZING ANTI-APOPTOTIC Bcl-2-FAMILY PROTEINSBURNHAM INST MEDICAL RESEARCH·Filed 2008·Application pending·0 cites
- 3250US7785900B1Glutathione beads and GST fusion proteinsSTC UNM·Filed 2007·Granted Aug 31, 2010·0 cites·37 claims
- 3348US2009069324A1Chemical inhibitors of bfl-1 and related methodsBURNHAM INST·Filed 2008·Application pending·0 cites
- 3445US2021087206A1Macrocyclic kinase inhibitors and their useTURNING POINT THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dayong Zhai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →